Stocks›Healthcare

Global Longlife Hospital and R

GLHRL · BSE · Healthcare · As of 8 Nov 2026

₹15.10

+₹0.65 (+4.50%)(1D)

₹9.0052 Week Range₹25.80

Market Cap

₹15.96 Cr

P/E (Sector)

— (32.3)

P/B Ratio

—

Dividend Yield

—

ROE

3.8%

Debt / Equity

—

Anvest Score

35/100

Valuation

75/100

Quality

8/100

Growth

—

Omitted

Health

12/100

Momentum

50/100

Valuation
75
Quality
8
Growth
—
Health
12
Momentum
50

AI Company ProfileFiling-backed

AI Snapshot

The company's operations are characterized by an absence of inventory and minimal interest expenses, leading to significant variances in key financial ratios like Inventory Turnover and Interest Coverage.

HospitalFounded:2012CEO/MD:Dhruv Sureshkumar JaniHQ:Ahmedabad, Gujarat

Business profile as of period ended 25 Aug 2026

PAT growth: N/M3Y CAGR
CFO / PAT: N/MFY26

What Looks Strong

No material strength identified from currently verified evidence.

What to Watch

EarningsThe company reported a net loss in FY26 (standalone: ₹-1.7 cr). Watch the path back to profitability and operational turnaround.
MarketShares have lagged the Nifty 500 by 42.4 percentage points annualized over three years.

Loading company profile…

Fundamentals

P/E Ratio (TTM)

—

Sector median P/E

32.29

P/B Ratio

—

Sector median P/B

4.4

EPS (TTM)

—

Market Cap

₹15.96 Cr

ROE

3.8%

ROCE

-9.43%

Profit Margin

3.58%

Global Longlife Hospital and R FAQs

3 topics

Expand

What does the Global Longlife Hospital and R (GLHRL) stock page cover?

Global Longlife Hospital and R on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for GLHRL?

Global Longlife Hospital and R is currently shown with a delayed price near ₹15.1, P/E N/A, and ROE 3.8%.

Does the GLHRL page provide investment advice?

No. The GLHRL page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring